Alzheimers SPECIAL REPORT: FINANCIAL AND PERSONAL BENEFITS OF EARLY DIAGNOSIS

SPECIAL REPORT: FINANCIAL AND PERSONAL BENEFITS OF EARLY DIAGNOSIS

Early diagnosis of Alzheimer's provides a number of important benefits to diagnosed individuals, their caregivers and loved ones, as well as society as a whole.
The development of biomarkers for Alzheimer's disease is making it possible to detect Alzheimer's disease and provide an accurate diagnosis earlier than at any other time in history. In addition to providing significant medical, emotional and social benefits and facilitating participation in important clinical trials, early diagnosis enables individuals to prepare legal, financial and end-of-life plans while they are still cognitively able to make decisions and share their wishes.
Early diagnosis, even without biomarker evidence for a specific underlying cause, will also yield significant cost savings in medical and long-term care for both the U.S. government and diagnosed individuals.
Among all Americans alive today, if those who will get Alzheimer's disease were diagnosed in the mild cognitive impairment (MCI) stage — before dementia — it would collectively save $7 trillion to $7.9 trillion in health and long-term care costs.

SPECIAL REPORT: FINANCIAL AND PERSONAL BENEFITS OF EARLY DIAGNOSIS

Early diagnosis of Alzheimer's provides a number of important benefits to diagnosed individuals, their caregivers and loved ones, as well as society as a whole.
The development of biomarkers for Alzheimer's disease is making it possible to detect Alzheimer's disease and provide an accurate diagnosis earlier than at any other time in history. In addition to providing significant medical, emotional and social benefits and facilitating participation in important clinical trials, early diagnosis enables individuals to prepare legal, financial and end-of-life plans while they are still cognitively able to make decisions and share their wishes.
Early diagnosis, even without biomarker evidence for a specific underlying cause, will also yield significant cost savings in medical and long-term care for both the U.S. government and diagnosed individuals.
Among all Americans alive today, if those who will get Alzheimer's disease were diagnosed in the mild cognitive impairment (MCI) stage — before dementia — it would collectively save $7 trillion to $7.9 trillion in health and long-term care costs.

Comments

Popular posts from this blog

HOW TO PREVENT FLEAS WITH SKIN SO SOFT on Your Pets Skin So Soft for Controlling Fleas on Dogs and pets

As a participant in the Alzheimer's Association Walk to End Alzheimer'